BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12932117)

  • 1. Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts.
    Sakaki T; Naruse H; Masai M; Takahashi K; Ohyanagi M; Iwasaki T; Fukuchi M
    Ann Nucl Med; 2003 Jun; 17(4):321-6. PubMed ID: 12932117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease.
    Kosaka T; Nakagawa M; Ishida M; Iino K; Watanabe H; Hasegawa H; Ito H
    J Cardiol; 2009 Oct; 54(2):262-72. PubMed ID: 19782264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
    Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
    Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of a dual L/N-type Ca2+ channel blocker, cilnidipine, in patients with chronic heart failure: assessment with 123I-MIBG myocardial scintigraphy].
    Ito K; Sugihara H; Nishikawa S; Adachi Y; Kato S; Azuma A; Matsubara H
    Kaku Igaku; 2003 Nov; 40(4):421-30. PubMed ID: 14733106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Switching from Cilnidipine to Azelnidipine on Cardiac Sympathetic Nerve Function in Patients with Heart Failure Preserved Ejection Fraction.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Ikeda T
    Int Heart J; 2018 Jan; 59(1):120-125. PubMed ID: 29269711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cilnidipine on sympathetic outflow and sympathetic arterial pressure and heart rate regulations in rats.
    Yamamoto H; Kawada T; Shimizu S; Kamiya A; Miyazaki S; Sugimachi M
    Life Sci; 2013 Jul; 92(24-26):1202-7. PubMed ID: 23688866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
    Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T
    Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
    Sakata K; Shirotani M; Yoshida H; Nawada R; Obayashi K; Togi K; Miho N
    Hypertension; 1999 Jun; 33(6):1447-52. PubMed ID: 10373231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
    Aritomi S; Konda T; Yoshimura M
    Heart Vessels; 2012 Jul; 27(4):419-23. PubMed ID: 21989861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients.
    Kitahara Y; Saito F; Akao M; Fujita H; Takahashi A; Taguchi H; Hino T; Otsuka Y; Kushiro T; Kanmatsuse K
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):68-73. PubMed ID: 14668570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients.
    Ito T; Fujimoto N; Ishikawa E; Dohi K; Fujimoto M; Murata T; Kiyohara M; Takeuchi H; Koyabu S; Nishimura H; Takeuchi T; Ito M
    Clin Exp Hypertens; 2019; 41(1):92-99. PubMed ID: 29584458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
    Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
    J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
    Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
    Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard.
    Minami J; Ishimitsu T; Kawano Y; Numabe A; Matsuoka H
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):331-6. PubMed ID: 9700998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of white coat effect by cilnidipine in essential hypertension.
    Morimoto S; Takeda K; Oguni A; Kido H; Harada S; Moriguchi J; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Am J Hypertens; 2001 Oct; 14(10):1053-7. PubMed ID: 11710785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-dose nifedipine GITS on sympathetic activity in young and older patients with hypertension.
    Ruzicka M; Coletta E; Floras J; Leenen FH
    J Hypertens; 2004 May; 22(5):1039-44. PubMed ID: 15097246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cilnidipine on insulin sensitivity in patients with essential hypertension.
    Yagi S; Goto S; Yamamoto T; Kurihara S; Katayama S
    Hypertens Res; 2003 May; 26(5):383-7. PubMed ID: 12887129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.